Project Details
Description
Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector
| Status | Active |
|---|---|
| Effective start/end date | 8/8/23 → 8/31/33 |
Funding
- GENETIX BIOTHERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.